Physician profile
Thomas J Watson
NPI 1326076209
$11,951.86
in general payments reported to CMS, 2019-2025
17 companies · $1,528 in 2025
The $1,528 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,986 · 2020: $434 · 2021: $144 · 2022: $6,151 · 2023: $210 · 2024: $498 · 2025: $1,528.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542 · Travel and Lodging: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.31 |
| Travel and Lodging | $694.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,622.76 | 2019-2025 | |
| Medtronic, INC. | $917.16 | 2023-2025 | Signia |
| Olympus America INC. | $875.21 | 2019 | |
| Medical Device Business Services, INC. | $731.49 | 2019 | |
| Ethicon INC. | $448.81 | 2019-2025 | Monarch Platform |
| Asensus Surgical, INC. | $447.58 | 2019 | |
| Davol INC. | $161.09 | 2019-2020 | |
| Lemaitre Vascular, INC. | $124.81 | 2025 | Restoreflow |
| Pinnacle Biologics, INC | $115.57 | 2019 | |
| Advanced Accelerator Applications | $107.89 | 2020 | |
| Solventum Corporation | $92.51 | 2025 | V.A.C. Veraflo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $86.61 | 2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $53.38 | 2025 | |
| Becton, Dickinson and Company | $51.53 | 2019 | |
| Covidien LP | $40.68 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $38.46 | 2022 | |
| Ethicon US, LLC | $36.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.